Boost Search Results
Off
ADAA offers an annual award to an early career investigator for the best original research paper on neurobiology, psychopharmacology, psychosocial treatments, or experimental psychopathology of anxiety disorders and depression. This award is named for Donald F. Klein, MD (1928-2019), who revolutionized psychiatric thinking through his discovery in the early 1960s that imipramine, a recently developed psychotropic medication, was effective in blocking panic attacks. This opportunity is open to members and nonmembers.
Join Our Email List to Be Notified When 2027 Applications Open
Have a question? Please email [email protected].
Meet the 2026 Klein Awardee:
Nicole Short, PhD
Dr. Nicole A. Short is an Assistant Professor of Psychology at the University of Nevada, Las Vegas and a licensed clinical psychologist with training in translational science and patient-oriented research. Her research focuses on the etiology, prevention, and treatment of co-occurring posttraumatic stress disorder (PTSD) and substance use disorder (SUD), particularly cannabis use disorder (CUD). Her work has focused on three interrelated lines of inquiry: 1) identifying and elucidating mechanisms underlying transdiagnostic risk factors for PTSD and CUD, including insomnia symptoms and anxiety sensitivity; 2) leveraging this basic science work to develop and test scalable cognitive behavioral interventions that can prevent or treat co-occurring PTSD and CUD; and 3) extending these methods to other common PTSD comorbidities, including pain and suicide risk, and among high risk samples including recent sexual assault survivors. To date, she has published over 90 peer-reviewed publications (52 first or senior author). Currently, she is supported by a NIDA Career Development Award (K23DA054299-01A1) to further augment her training in: 1) conducting clinical trials in real-world clinical settings for sexual assault survivors at risk for PTSD and CUD (i.e., emergency care), and 2) incorporating intensive longitudinal methods, such as daily monitoring surveys and physiological data from wearable devices, into such clinical trials. She also serves or has served as PI on other research grants, including from the American Foundation on Suicide Prevention, the American Psychological Association, and the MayDay fund. In addition to clinical trials methodology, her research has also incorporated experimental psychopathology, elicitation and assessment of the human stress response, ecological momentary assessment, and observational cohort study designs.
Thank you to our Klein Award Reviewers: Charles B. Nemeroff, MD, PhD and Alicia Meuret, PhD
- 2025 Awardees: Emily M. Becker-Haimes, PhD, and Mohammad Sendi, PhD
- 2024 Awardee: Kristin Szhuhany, PhD
- 2023 Awardee: Emily Belleau, PhD
- Meet the 2010-2024 Klein Awardees
- View the 2022 Awardee Research Feature Webinar: Sage Hawn, PhD
- View the 2021 Awardee and Runner-Up Research Feature Webinars: Annmarie MacNamara, PhD and Hilary Weingarden, PhD
Add bio
Award Components
- A $1000 cash award
- Complimentary registration to the ADAA Annual Conference (a $500 value)
- Complimentary two year ADAA annual membership (up to a $578 value)
- Research paper will be automatically considered for acceptance in ADAA’s online scientific journal published by Elsevier - The Journal of Mood & Anxiety Disorders,® and the article processing charge of $2,700 will be waived.
- Award presented at the Annual Conference.
- Opportunity to present research as a poster at the ADAA Annual Conference.
- Featured profile on the ADAA website
Please note that the Klein award does not provide a travel or hotel allowance. ADAA strongly suggests awardees book their stay at the conference hotel.
No
Award Eligibility
- Restricted to investigators who have completed their terminal degree and are currently at a rank of assistant professor or below.
- Individuals who are working to complete their degree are not eligible.\
- Must be first or senior author on the submitted paper, which must be original research on anxiety disorders, depression, and comorbid related disorders, focusing on neurobiology, psychosocial treatments, or experimental psychopathology.
- The paper cannot be submitted or under review anywhere else from submission until notification about the award (including ADAA's Journal of Mood and Anxiety Disorders®)
- ADAA recognizes, supports, and values the inclusion of diverse groups, educational backgrounds, and views. ADAA also encourages interdisciplinary as well as international applicants.
- Awardee(s) are invited to host a recorded non-CE webinar on the research topic of the paper within three months after the Conference. An Honorarium is not provided.
- ADAA Board Members and Scientific Council members are not eligible.
Please note: A Klein awardee, if they choose, can participate in the entire CDLP program. To participate in the CDLP program (held on the Thursday of every ADAA annual conference), the Klein awardee must register for the conference. The conference registration fee is waived.
No
Application Requirements
- Headshot, biosketch, CV
- Research Manuscript (include abstract, no page limit)
- Letter of Reference from a previous or current mentor/advisor
No
About Donald F. Klein
This award is named for Donald F. Klein, MD (1928-2019), who revolutionized psychiatric thinking through his discovery in the early 1960s that imipramine, a recently developed psychotropic medication, was effective in blocking panic attacks. Dr. Klein’s early contribution to the development of the DSM in large part gave birth to the modern branch of medical science dealing with the classification of disease of anxiety disorders. His early findings also heralded in the era of childhood anxiety disorders as biochemical disorders when he discovered that imipramine blocked childhood separation anxiety disorders.
In later years, Dr. Klein developed a compelling evolutionary-based hypothesis accounting for the etiology of panic disorders, which he terms “the false suffocation alarm theory of panic disorders.” His work remains relevant and topical to the present. Dr. Klein was the recipient of the 2005 ADAA Lifetime Achievement Award.
No
